The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.
about
Beta-estradiol attenuates hypoxic pulmonary hypertension by stabilizing the expression of p27kip1 in rats.The COP9 signalosome and vascular function: intriguing possibilities?Arterial territory-specific phosphorylated retinoblastoma protein species and CDK2 promote differences in the vascular smooth muscle cell response to mitogens.Cell cycle regulator geminin is dispensable for the proliferation of vascular smooth muscle cells.2,3,4',5-Tetrahydroxystilbene-2-O-β-d-glucoside inhibits platelet-derived growth factor-induced proliferation of vascular smooth muscle cells by regulating the cell cycle.The effects of artemisinin on the proliferation and apoptosis of vascular smooth muscle cells of rats.
P2860
The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.
@ast
The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.
@en
type
label
The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.
@ast
The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.
@en
prefLabel
The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.
@ast
The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.
@en
P2093
P2860
P1476
The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.
@en
P2093
Bradley H Strauss
Nafiseh Nili
Thierry Charron
P2860
P304
P356
10.1016/S0828-282X(06)70986-2
P478
22 Suppl B
P577
2006-02-01T00:00:00Z